Tara Akhshi

Harvard University — United States

Medicine · Health Sciences

2h-index18citations73works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(53), Immunotherapy and Immune Responses(25), Advanced biosensing and bioanalysis techniques(21), Advanced Biosensing Techniques and Applications(16), Estrogen and related hormone effects(13)

Publications73 total

Supplementary Fig. S7 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S3 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S6 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S5 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S1 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S4 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Tables S2-13 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S8 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Fig. S2 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Supplementary Table S1 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
2025Open Access
Tamoxifen induces PI3K activation in uterine cancer
Nature Genetics·2025· 5 citedOpen Access
Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity
2025Open Access
Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity
2025Open Access
Supplementary Fig. S7 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
Supplementary Table S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
Supplementary Fig. S4 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
Supplementary Tables S2-13 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
Supplementary Tables S2-13 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Rinath Jeselsohn(49), Francisco Hermida‐Prado(47), Avery Feit(47), Agostina Nardone(47), Yingtian Xie(46), Shira Sherman(46), Zsuzsanna Nagy(46), Douglas Russo(46), Zhengtao Chu(46), Marco Campisi(46), Minyue Chen(46), Cristina Guarducci(46), Klothilda Lim(46), Alba Font‐Tello(46), Irene Lee(46), Juana García-Pedrero(46), Israel Cañadas(46), Judith Agudo(46), Ying Huang(46), Tal Sella(46)